DILLON WADE: Open Payments
NPI 1023523644 · KELLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,021 in 114 payments from 26 companies in 2025. Trend: 2023 $2,793 · 2024 $2,119 · 2025 $2,021
Food & beverage: $2,021
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 10 | $320 |
| PFIZER INC. | 19 | $313 |
| Novo Nordisk Inc | 11 | $184 |
| Antares Pharma, Inc. | 13 | $179 |
| ABBVIE INC. | 14 | $174 |
| Esperion Therapeutics, Inc. | 6 | $94 |
| Axsome Therapeutics, Inc. | 4 | $84 |
| Lilly USA, LLC | 5 | $82 |
| Abbott Laboratories | 3 | $73 |
| TOLMAR, INC. | 4 | $65 |
Products named: Korlym, XYOSTED, NURTEC ODT, NEXLETOL, Ozempic, QULIPTA, PREVNAR 20, JARDIANCE.
Industry payments across TX — which companies pay providers there.
